๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Locally Advanced Cervical Cancer
Clinical trial register · China

Locally Advanced Cervical Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Chongqing 6 Changsha 4 Beijing 4 Wuhan 3 Hefei 3
Narrow the registerReset
Recruitment status
Phase
Site location
Chongqing6 Changsha4 Beijing4 Wuhan3 Hefei3
All 16 locations
Target enrolment
to

Locally Advanced Cervical Cancer trials in China

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Perioperative Adebrelimab for Locally Advanced Cervical Cancer
NCT07811375Locally Advanced Cervical Cancer
Anhui Provincial Hospital
Phase 2
35
Hefei
2026-10-01
Recruiting
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT07338487Locally Advanced Cervical Cancer, Cachexia
Second Xiangya Hospital of Central South University
Phase 1
88
Changsha
2026-04-30
Recruiting
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
NCT07055399Locally Advanced Cervical Cancer
Fujian Cancer Hospital
Phase 2
43
Fuzhou
2025-08-21
Not yet open
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC
NCT06916117Locally Advanced Cervical Cancer
RenJi Hospital
Phase 2
30
Shanghai
2025-04-05
Active, closed
QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer
NCT07205497Neoadjuvant Immunotherapy, Locally Advanced Cervical Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
54
Guangzhou
2025-03-28
Not yet open
A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
NCT06882473Locally Advanced Cervical Cancer
Peking University Third Hospital
Not applicable
20
Beijing
2025-03-15
By invitation
CNCMT๏ผša Multi-center, Prospective, Single-arm Study
NCT06714084Locally Advanced Cervical Cancer, PD1, CTLA4
Hubei Cancer Hospital
Not applicable
20
Wuhan
2024-10-08
Recruiting
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
NCT06288360Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative, Neoadjuvant Chemoimmunotherapy
Tongji Hospital
Phase 2
40
Hefei, Beijing, Chongqing, Lanzhou, Nanning, Wuhan, Changsha, Shenyang
2024-09-12
Recruiting
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
NCT06288373Cervical Cancer, Locally Advanced Cervical Cancer, Concurrent Chemoradiotherapy, Neoadjuvant Chemoimmunotherapy
Tongji Hospital
Phase 2/3
440
Hefei, Beijing, Chongqing, Lanzhou, Nanning, Wuhan, Changsha, Shenyang
2024-04-22
Recruiting
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
NCT06055738Locally Advanced Cervical Cancer
Tang-Du Hospital
Phase 2
20
Xi'an
2023-10-09
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
NCT06079671Locally Advanced Cervical Cancer
AstraZeneca
Phase 3
800
Beijing, Changde, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou
2023-09-22
Not yet open
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
NCT05799469Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2
36
Chongqing
2023-05-01
Recruiting
Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer
NCT05687851Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2
33
Chongqing
2022-12-29
Recruiting
Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
NCT05950087Locally Advanced Cervical Cancer
Guizhou Provincial People's Hospital
Observational
30
Guiyang
2022-11-01
Recruiting
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
NCT05378087Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Not applicable
1,956
Chongqing
2022-06-27
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/locally-advanced-cervical-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Locally Advanced Cervical Cancer.

How many Locally Advanced Cervical Cancer trials are recruiting in China?

9 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Locally Advanced Cervical Cancer), 15 studies
PhaseStudiesRecruitingShare
Phase 28453.3%
Not applicable3120%
Observational116.7%
Phase 1116.7%
Phase 2/3116.7%
Phase 3116.7%

Most active sponsors

Lead sponsors with the most studies (Locally Advanced Cervical Cancer)
Lead sponsorStudiesRecruiting
Chongqing University Cancer Hospital32
Tongji Hospital22
Anhui Provincial Hospital10
AstraZeneca11
Fujian Cancer Hospital11
Guizhou Provincial People's Hospital11
Hubei Cancer Hospital10
Peking University Third Hospital10
RenJi Hospital10
Second Xiangya Hospital of Central South University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.